Acta Neuropathologica

, Volume 135, Issue 4, pp 643–646 | Cite as

Integrated neurodegenerative disease autopsy diagnosis

Correspondence

Notes

Acknowledgements

EBL is supported by Grants from the National Institutes of Health (R01NS095793, P30AG010124, P50NS053488, P01AG017586 and R01NS094003). Special thanks to my colleagues at the University of Pennsylvania for their thoughtful input.

References

  1. 1.
    Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E et al (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309–320.  https://doi.org/10.1007/s00401-009-0485-4 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS et al (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946CrossRefPubMedGoogle Scholar
  3. 3.
    Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK et al (2009) Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol 8:1150–1157.  https://doi.org/10.1016/S1474-4422(09)70238-8 CrossRefPubMedGoogle Scholar
  4. 4.
    Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676.  https://doi.org/10.1212/01.wnl.0000324625.00404.15 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019CrossRefPubMedGoogle Scholar
  6. 6.
    Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8:1–13.  https://doi.org/10.1016/j.jalz.2011.10.007 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097CrossRefPubMedGoogle Scholar
  8. 8.
    Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55–65.  https://doi.org/10.1016/S1474-4422(16)30291-5 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262.  https://doi.org/10.1016/j.jalz.2011.03.004 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kapasi A, DeCarli C, Schneider JA (2017) Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 134:171–186.  https://doi.org/10.1007/s00401-017-1717-7 CrossRefPubMedGoogle Scholar
  11. 11.
    Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M, Lee VM, Irwin DJ et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65–78.  https://doi.org/10.1007/s00401-017-1679-9 CrossRefPubMedGoogle Scholar
  12. 12.
    Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C et al (2014) International society of neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435.  https://doi.org/10.1111/bpa.12171 CrossRefPubMedGoogle Scholar
  13. 13.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820.  https://doi.org/10.1007/s00401-016-1545-1 CrossRefPubMedGoogle Scholar
  14. 14.
    Mackenzie IR, Neumann M (2017) Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol 134:79–96.  https://doi.org/10.1007/s00401-017-1716-8 CrossRefPubMedGoogle Scholar
  15. 15.
    Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111–113.  https://doi.org/10.1007/s00401-011-0845-8 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1–4.  https://doi.org/10.1007/s00401-009-0612-2 CrossRefPubMedGoogle Scholar
  17. 17.
    McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100.  https://doi.org/10.1212/WNL.0000000000004058 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269.  https://doi.org/10.1016/j.jalz.2011.03.005 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11.  https://doi.org/10.1007/s00401-011-0910-3 CrossRefPubMedGoogle Scholar
  20. 20.
    Nelson PT, Kukull WA, Frosch MP (2010) Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol 69:449–454.  https://doi.org/10.1097/NEN.0b013e3181d8db07 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456–2477.  https://doi.org/10.1093/brain/awr179 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Seeley WW (2017) Mapping neurodegenerative disease onset and progression. Cold Spring Harb Perspect Biol 9:a023622.  https://doi.org/10.1101/cshperspect.a023622 CrossRefPubMedGoogle Scholar
  23. 23.
    Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800CrossRefPubMedGoogle Scholar
  24. 24.
    Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S et al (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 68:162–172.  https://doi.org/10.1002/ana.22094 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Translational Neuropathology Research LaboratoryUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations